Covista Inc. (CVSA) Stock Analysis
Momentum Cont setup
Consumer Defensive · Education & Training Services
Hold if already holding. Not a fresh buy at $124.06, but acceptable to hold if already in. Reasons: Thin upside margin: 7.1%; Weak overall score: 4.9/10.
Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make... Read more
Hold if already holding. Not a fresh buy at $124.06, but acceptable to hold if already in. Reasons: Thin upside margin: 7.1%; Weak overall score: 4.9/10. Chart setup: Trend continuation, RSI 59, MACD bullish. Maintain position. Not compelling to add more. Score 4.9/10, moderate confidence.
Passes 7/10 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 78d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.
Recent Developments — Covista Inc.
Latest news
- CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Top Analyst Buy Signal — Newser positive
- CVSA Covista posts 8.9 percent Q1 2026 earnings per share beat, shares rise 1.29 percent today. - Expert Verified Trades — Newser positive
- Here's why Covista (CVSA) is a strong value stock - MSN — MSN positive
- Here's Why Covista (CVSA) is a Strong Value Stock - Yahoo Finance — Yahoo Finance positive
- Earnings To Watch: Covista (CVSA) Reports Q1 Results Tomorrow - StockStory — StockStory neutral
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-03-03Item 1.02MEDIUM**Delaware** | **001-13988** | **36-3150143** (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | **233 South Wacker Drive** **Chicago****,****IL** | | **60606** (Address of principal executive offices) | | (Zip Code) **(****312****)...SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $124.06, but acceptable to hold if already in. Reasons: Thin upside margin: 7.1%; Weak overall score: 4.9/10. Chart setup: Trend continuation, RSI 59, MACD bullish. Maintain position. Not compelling to add more. Target $132.81 (+7.1%), stop $115.36 (−7.5%), A.R:R 0.5:1. Score 4.9/10, moderate confidence.
Take-profit target: $132.81 (+7.1% upside). Target $132.81 (+7.1%), stop $115.36 (−7.5%), A.R:R 0.5:1. Stop-loss: $115.36.
Thin upside margin: 7.1%; Weak overall score: 4.9/10; Weak growth.
Covista Inc. trades at a P/E of 18.3 (forward 14.3). TrendMatrix value score: 7.1/10. Verdict: Hold.
10 analysts cover CVSA with a consensus score of 4.3/5. Average price target: $156.
What does Covista Inc. do?Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse...
Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make inspiring contributions to our global community.